Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$17,626,824
+$776,638 QoQ
Shares Held
14,696
-19.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#951
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sigma Planning Corp holds $73,658,587 across 13 Drug Manufacturers - General names. LLY ranks #1 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
14,696 | $17,626,824 | |
| 2 | JNJ |
Johnson & Johnson
|
62,029 | $15,753,505 | |
| 3 | ABBV |
AbbVie Inc.
|
55,986 | $14,088,317 | |
| 4 | MRK |
Merck & Co., Inc.
|
45,541 | $5,852,018 | |
| 5 | AMGN |
Amgen Inc
|
14,019 | $5,076,560 | |
| 6 | PFE |
Pfizer Inc
|
210,735 | $5,074,498 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
76,251 | $4,393,582 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
13,992 | $1,767,749 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,626,824 | 14,696 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $16,850,186 | 18,320 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $18,334,042 | 17,060 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $12,387,305 | 16,235 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $12,894,205 | 16,541 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $13,791,871 | 16,699 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $13,385,708 | 17,339 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $16,585,682 | 18,721 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $16,951,429 | 18,723 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $16,034,533 | 20,611 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $7,994,747 | 13,715 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $11,409,178 | 21,241 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $10,784,195 | 22,995 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $8,242,766 | 24,002 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $7,221,681 | 19,740 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $6,031,770 | 18,654 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,759,297 | 17,763 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,567,887 | 15,951 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $4,662,317 | 16,879 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,477,302 | 15,050 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $3,534,148 | 15,398 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,987,812 | 15,993 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,534,963 | 15,014 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,678,717 | 18,097 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $2,518,357 | 15,339 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $2,039,738 | 14,704 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||